2000
DOI: 10.1177/107327480000700401
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Mechanisms and Pathways in Bladder Cancer Development and Progression

Abstract: Background: The basis for bladder cancer development and progression is complex and involves genetic abnormalities. These abnormalities yield phenotypic changes that allow normal transitional cells to becomeity of these new cases, approximately 75%, are limited to the mucosa (stage Ta or Tis) and lamina propria (T1) at presentation, and most of these tumors can be removed by transurethral resection. Recurrence rates are high (30% to 85%), and 10% to 30% of "superficial" tumors (T1 or less) will subsequently pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
52
0
5

Year Published

2001
2001
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 85 publications
(58 citation statements)
references
References 65 publications
1
52
0
5
Order By: Relevance
“…Hence, bladder cancer susceptibility depends on the cumulative expression profiles of these activating and detoxifying enzymes. It also means that exposures to occupational agents and cigarette smoke may be additive ( Jung & Messing, 2000).…”
Section: Occupational Exposurementioning
confidence: 99%
See 1 more Smart Citation
“…Hence, bladder cancer susceptibility depends on the cumulative expression profiles of these activating and detoxifying enzymes. It also means that exposures to occupational agents and cigarette smoke may be additive ( Jung & Messing, 2000).…”
Section: Occupational Exposurementioning
confidence: 99%
“…The ras oncogene does not seem to be strongly implicated in the differential process of carcinogenesis in SABC, judging from studies in different countries (Czerniak et al, 1990, Ibrahim & Khaled,2006. Deletions on chromosome 9 not only appear to occur in > 60% of bladder cancer across all grades and stages, but also are likely an initiating event (Jung & messing 2000). The p21 region of chromosome 9 (9p21) has been found to be mutated in a variety of malignancies suggesting the presence of a common tumor suppressor gene.…”
Section: Cancer Genesmentioning
confidence: 99%
“…Bun la rın en iyi bi li ne ni ve en baş ta ge le ni si ga ra dır. 4 Si ga ra içen ler de, me sa ne tü mo rü ge liş me ris ki nin or tala ma 3-7 kat art tı ğı bil di ril miş tir. 1 Me sa ne tü mö -rü nün eti yo pa to ge ne zinde tü tün de yer alan ben zo(a)pi ren, po li sik lik aro ma tik hid ro kar bon lar ve aro ma tik amin le rin (2-naf ti la min, 4-ami no bi fenil) önem li rol oy na dı ğı be lir len miş tir.…”
Section: Me Sa Ne Kan Se Ri̇ Ni̇n Eti̇ Yo Lo Ji̇ Si̇unclassified
“…8 Me sa ne kan se ri nin, en düs tri yel kar sino jen le re uzun yıl lar ma ruz ka lın dık tan son ra uzun bir la tent per yo dun ar dın dan ge li şe bi le ce ği de ğer -len di ril mek te dir. 4 Ba zı me ta bo liz ma en zim le rin de ki gen po limor fizm le ri nin, en zim le rin "in vi vo " ifa de se vi yele rin de ve do la yı sıy la kse no bi yo tik me ta bo liz masın da olu şan de ği şik lik le re bağ lı ola rak, has ta lık ge li şi min de ve iler le me sin de, ki şi sel risk fark lı lık -la rı na ne den ol du ğu bil di ril mek te dir. 9,10 Si tok rom p450 ve glu tat yon s-trans fe raz gen le ri nin po limor fizm le ri, en do jen me ta bo lit le rin ve kse no biyo tik le rin me ta bo liz ma sın da bi rey ler ara sın da ki fark lı lık tan so rum lu ol ma sı ne de niy le çe şit li kanser araş tır ma la rın da mo le kü ler epi de mi yo lo ji ça lış -ma la rı nın il gi oda ğı ol muş tur.…”
Section: Me Sa Ne Kan Se Ri̇ Ni̇n Eti̇ Yo Lo Ji̇ Si̇unclassified
See 1 more Smart Citation